We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+14.6%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$500B
AUM Growth
+$33.8B
Cap. Flow
-$25.4B
Cap. Flow %
-5.08%
Top 10 Hldgs %
30.95%
Holding
15,795
New
1,585
Increased
6,018
Reduced
6,315
Closed
1,625

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.38B
2
NVDA icon
NVIDIA
NVDA
+$732M
3
AMZN icon
Amazon
AMZN
+$606M
4
DIS icon
Walt Disney
DIS
+$559M
5
T icon
AT&T
T
+$466M

Sector Composition

Rank Sector Weight
1 Technology 3.81%
2 Healthcare 2.95%
3 Financials 2.19%
4 Consumer Discretionary 2.15%
5 Industrials 1.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXFY icon
13601
PUT
Expensify
EXFY
$210M
$2.47K ﹤0.01%
1,000
-1,600
-62% -$4.14K
DRIV icon
13602
PUT
Global X Autonomous & Electric Vehicles ETF
DRIV
$398M
$2.47K ﹤0.01%
100
-200
-67% -$4.59K
ASMB icon
13603
CALL
Assembly Biosciences
ASMB
$653M
$2.46K ﹤0.01%
250
-633
-72% -$6.02K
VMCAW
13604
DELISTED
Valuence Merger Corp. I Warrant
VMCAW
$2.46K ﹤0.01%
81,831
-7,600
-8% -$207
CCLP
13605
CALL
DELISTED
CSI Compressco LP
CCLP
$2.44K ﹤0.01%
1,500
-11,700
-89% -$17.5K
AKYA
13606
PUT
DELISTED
Akoya BioSciences
AKYA
$2.44K ﹤0.01%
500
-900
-64% -$3.74K
EMX
13607
PUT
DELISTED
EMX Royalty
EMX
$2.43K ﹤0.01%
1,500
-1,700
-53% -$2.9K
TMTCR
13608
DELISTED
TMT Acquisition Corp Rights
TMTCR
$2.43K ﹤0.01%
11,149
-720
-6% -$177
YTEN
13609
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$2.42K ﹤0.01%
421
-686
-62% -$4.56K
TRVI icon
13610
CALL
Trevi Therapeutics
TRVI
$2.63B
$2.41K ﹤0.01%
+1,800
New +$2.73K
DRIO icon
13611
CALL
DarioHealth
DRIO
$73.9M
$2.41K ﹤0.01%
70
-265
-79% -$9.44K
TRTL.WS
13612
DELISTED
TortoiseEcofin Acquisition Corp. III Warrant, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TRTL.WS
$2.4K ﹤0.01%
26,939
-4,993
-16% -$539
EOSEW
13613
Eos Energy Enterprises Warrant
EOSEW
$28.1M
$2.39K ﹤0.01%
+11,971
New +$3.46K
TOUR
13614
CALL
Tuniu
TOUR
$53.2M
$2.38K ﹤0.01%
+350
New +$3.08K
TCRT icon
13615
PUT
Alaunos Therapeutics
TCRT
$4.71M
$2.37K ﹤0.01%
223
-261
-54% -$3.14K
BHACW
13616
DELISTED
Focus Impact BH3 Acquisition Company Warrants
BHACW
$2.35K ﹤0.01%
39,226
+4,317
+12% +$173
SPNT icon
13617
PUT
SiriusPoint
SPNT
$2.76B
$2.32K ﹤0.01%
200
HSCSW icon
13618
HeartSciences Inc Warrant
HSCSW
$2.32K ﹤0.01%
28,978
+813
+3% +$52
TBIO
13619
CALL
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$2.31K ﹤0.01%
322
+211
+190% +$2.34K
SPCK
13620
PUT
The SPAC and New Issue ETF
SPCK
$8.32M
$2.3K ﹤0.01%
100
-400
-80% -$9.36K
MKFG
13621
PUT
DELISTED
Markforged Holding Corporation
MKFG
$2.3K ﹤0.01%
280
-190
-40% -$1.66K
KACLR
13622
DELISTED
Kairous Acquisition Corp. Limited Rights
KACLR
$2.29K ﹤0.01%
25,961
-1,500
-5% -$162
HYPD
13623
PUT
Hyperion DeFi Inc
HYPD
$41.2M
$2.29K ﹤0.01%
14
-115
-89% -$13.6K
QNTM
13624
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$24.4M
$2.28K ﹤0.01%
+38
New +$2.68K
IYZ icon
13625
PUT
iShares US Telecommunications ETF
IYZ
$1.23B
$2.28K ﹤0.01%
100
-9,500
-99% -$204K

Similar funds

Ken Griffin's Q4 2023 Portfolio in Review

As of Q4 2023, Ken Griffin held 15,795 positions worth $500B, up 7.2% from $467B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin withdrew a net $25.4B in Q4 2023, closing 1,625 positions and reducing 6,315 holdings. Its most notable exit was Activision Blizzard, an estimated $1.41B position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Ken Griffin opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $129M.

  • Ken Griffin's largest Q4 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,167,658 shares worth $129M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.38B increase.
  • Ken Griffin's biggest Q4 2023 reduction was Comcast, cutting an estimated $658M.
  • Ken Griffin fully exited Activision Blizzard in Q4 2023, selling an estimated $1.41B.
  • Ken Griffin's ten largest holdings make up 31% of its $500B portfolio in Q4 2023.
  • Ken Griffin opened 1,585 new positions and closed 1,625 in Q4 2023.
  • Ken Griffin's portfolio value rose 7.2% quarter-over-quarter to $500B.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.